Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 9, 2025Circulation Research

Abstract Thu036: Generation of induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYBPC3 mutations

View Full Paper
Ask AI
Bookmark
Share

Authors

CWCatherine A. WuMWMatthew A. WuSZShane Rui Zhao

Discussion

Loading...

Member takes

Overview

This research demonstrates the creation of induced pluripotent stem cell lines from HCM patients, indicating potential for studying disease mechanisms and developing treatments for MYBPC3 mutations.

Key Points

  • The study successfully created two induced pluripotent stem cell lines from HCM patients carrying MYBPC3 mutations, paving the way for advanced research.
  • Patient-specific iPSC lines showed high expression of pluripotency markers NANOG and SOX2, confirming reprogramming success.
  • Differentiation assays indicated these iPSC lines could develop into all three germ layers, demonstrating their pluripotency.
  • Future studies may explore the pathophysiology of hypertrophic cardiomyopathy to enhance treatment strategies.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/68e80eb363e2e2f707877dd8https://doi.org/10.1161/res.137.suppl_1.thu036
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Generation of two induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYBPC3 mutations2026 · 1 citations
  2. 2Establishment and characterization of induced pluripotent stem cells from an individual with familial hypertrophic cardiomyopathy carrying the MYBPC3 c.772G>A mutation2024
  3. 3Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation2024 · 1 citations
  4. 4Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy2021 · 9 citations
  5. 5Generation of an Induced Pluripotent Stem Cell Line ICGi047-A by Reprogramming Peripheral Blood Mononuclear Cells of a Hypertrophic Cardiomyopathy Patient with the Pathogenic Variant c.966G>A in MYBPC3 Gene2025